News about Global Pharma

Lupin Signs USD 50 million Deal with Zentiva to Commercialise Biosimilar Certolizumab Pegol Globally

Zentiva will be responsible for marketing and distribution of Lupin’s biosimilar Certolizumab Pegol outside the USA and Canada—primarily across Europe and the CIS (Commonwealth of Independent States) region.

Global Pharma | 09/07/2025 | By Dineshwori |  370

Nectar to Sell API, Formulations and Menthol Units to Ceph for INR 1,290 Cr

Nectar Lifesciences Ltd. is selling its core business division for INR 1,270 crore and its menthol business for INR 20 crore to Ceph Lifesciences.

Global Pharma | 09/07/2025 | By Dineshwori |  789

GSK Completes Acquisition of Efimosfermin from Boston Pharmaceuticals for USD 2 Billion

GSK has completed its acquisition of efimosfermin alfa, a Phase III-ready investigational therapy for serious liver diseases, from Boston Pharmaceuticals in a deal worth up to USD 2 billion.

Global Pharma | 09/07/2025 | By Mrinmoy Dey |  422

Mold-Tek Projects INR 30-35 Crore from Pharma Segment in FY26

Hyderabad-based Mold-Tek Packaging is witnessing strong growth in its pharmaceutical packaging segment, with ambitious targets of INR 30–35 crore in revenue for FY26 and INR 50–60 crore by FY27.

Global Pharma | 08/07/2025 | By Manvi |  210

Alembic Pharma Appoints Former Syngene VP G Krishnan as New CFO

G Krishnan has taken over as the new Chief Financial Officer (CFO) of Alembic Pharmaceuticals, succeeding R. K. Baheti.

Global Pharma | 08/07/2025 | By Manvi |  827

ACIP Dismissals Spark Regulatory Uncertainty as ADCs Surge in Biopharma Innovation

The action has sent shockwaves through the public health and vaccine development communities, raising concerns about regulatory continuity and future vaccine rollouts, according to GlobalData.

Global Pharma | 08/07/2025 | By Darshana |  265

Emcure Pharma Incorporates New Subsidiary Emcure Wellness to Widen Portfolio

Emcure Pharmaceuticals has announced the incorporation of a new wholly-owned subsidiary (WoS) named Emcure Wellness Private Limited in Pune, Maharashtra.

Global Pharma | 07/07/2025 | By Manvi |  681

Godavari Biorefineries' Patent for Anti-Cancer Molecule Now Validated in Spain, UK, and as a Unitary Patent Covering Multiple EU Member States

Godavari Biorefineries Ltd. has announced the validation of its European patent for a novel anti-cancer molecule in Spain, the UK, and as a Unitary Patent across multiple EU countries, marking a key milestone in its expansion into clinical-stage biotech and innovative cancer therapies.

Global Pharma | 07/07/2025 | By Mrinmoy Dey |  142

Pharma Faces $230 Billion Patent Cliff by 2030, Urging Strategic Shifts Amid Biosimilar Surge

Bristol Myers Squibb is likely to be among the hardest hit, with both Eliquis and Opdivo—major revenue contributors—set to go off-patent. GlobalData analyst George El-Helou notes that more than half of the top 15 pharma companies may struggle to absorb the impact, though some firms are leveraging promising pipeline drugs to cushion the blow.
<br />

Global Pharma | 07/07/2025 | By Darshana |  450

PM Modi Meets Cuban President at BRICS 2025, Discuss Strengthening Pharma Links

Prime Minister Modi proposed that Cuba recognise the Indian pharmacopoeia, a move that would pave the way for greater access to Indian generic medicines.

Global Pharma | 07/07/2025 | By Manvi |  334